Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Gastroesophageal Reflux Disease (GERD) Industry Expected To Reach By 2029, Starting From 2025 Levels?
The gastroesophageal reflux disease (gerd) market size has experienced marginal expansion in recent years. It is forecast to increase from $5.25 billion in 2024 to $5.33 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 1.6%. Contributing to its past growth are lifestyle and dietary changes, the obesity epidemic, growing awareness about gerd treatment, the globalization of the pharmaceutical industry, and investments for gerd treatments.
The gastroesophageal reflux disease (gerd) market size is anticipated to show consistent growth in the upcoming years. It is projected to expand to $5.95 billion by 2029, achieving a compound annual growth rate (CAGR) of 2.8%. This growth during the forecast period can be attributed to factors such as an aging population, increasing healthcare spending, the emergence of biomarkers, a rising number of GERD screening programs, a growing prevalence of heartburn, and an increased demand for medical equipment. Significant trends for this period include advancements in diagnostics and surgery, the development of targeted therapies, and the adoption of telehealth services.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
Which Drivers Are Supporting Growth Of The Gastroesophageal Reflux Disease (GERD) Market?
The increasing occurrence of esophageal ailments is projected to boost the expansion of the gastroesophageal reflux disease (GERD) market in the coming years. Esophageal diseases are medical conditions impacting the esophagus, the muscular tube linking the mouth to the stomach. Addressing these diseases aims to ease symptoms, enhance quality of life, and avert complications, thereby fostering improved overall health and well-being for individuals affected by gastroesophageal reflux disease. For instance, in January 2023, according to the American Cancer Society, a US-based Professional organization, approximately 21,560 new esophageal cancer cases are diagnosed annually in the United States, with 16,120 deaths from esophageal cancer. Consequently, the rising prevalence of esophageal conditions is a key factor propelling the growth of the gastroesophageal reflux disease (GERD) market.
What Are The Major Segments Identified In The Gastroesophageal Reflux Disease (GERD) Market?
The gastroesophageal reflux disease (gerd)market covered in this report is segmented –
1) By Drug Type: Antacids; Proton Pump Inhibitors; H2 Receptor Blocker; Pro Kinetic Agents; Dopamine Receptor Antagonist; EndoCinch; Stretta; EsophyX; Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive; Minimally Invasive
3) By End-Users: Hospital; Homecare; Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
3) By H2 Receptor Blockers: Ranitidine; Famotidine; Nizatidine; Cimetidine
4) By Prokinetic Agents: Metoclopramide; Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine; Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
How Are Trends Influencing The Gastroesophageal Reflux Disease (GERD) Market?
Leading companies operating within the gastroesophageal reflux disease (GERD) market are concentrating on unveiling innovative gastroesophageal reflux disease treatment devices to uphold their market position. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, debuted its new alpHaONE wireless pH-capsule reflux testing diagnostic system, which is engineered for diagnosing gastroesophageal reflux disease (GERD). This system provides monitoring data for up to 96 hours and features a compact design equipped with enlarged buttons and a reliable capsule delivery system. Additionally, the system includes a software application with a virtual instruction program and user-customizable symptom buttons, all contributing to an improved user experience.
Which Major Industry Participants Are Leading The Gastroesophageal Reflux Disease (GERD) Market Growth?
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Gastroesophageal Reflux Disease (GERD) Industry?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Gastroesophageal Reflux Disease (GERD) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2025, By The Business Research Company
Inflammatory Bowel Disease Treatment Global Market Report 2025
Irritable Bowel Syndrome Ibs Treatment Global Market Report 2025
Gastric Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model